How MRI & Genomics Could Prevent 1 in 6 Prostate Cancer Deaths
A new study suggests that screening for prostate cancer using genetic testing and a multiparametric MRI (mpMRI) scan before an invasive biopsy could prevent as many as 1 in 6 deaths from the disease and significantly reduce over-diagnosis and unnecessary treatment.[i] Researchers at the University College of London modeled the